Project Grant F32DA057800
Award Date
9/22/23
Completion Date
8/21/26
Dollars Obligated
$139K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $847,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Tennessee Health Science Center to conduct research on the therapeutic potential of neuropeptide S receptor 1 (NPSR1) agonism for reducing opioid self-administration and opioid relapse. The research team plans to leverage pharmacological tools for NPSR1 agonism and antagonism, and well-validated preclinical models, to rapidly...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $234,000 to Georgetown University to study the effects of opioids on HIV transcription and latency. The research aims to understand how opioids influence the progression of HIV in the central nervous system, particularly in glial cells like microglia and astrocytes. Utilizing a novel dual fluorescent and bioluminescent HIV virus, the researchers...
The U.S. National Institute on Drug Abuse (NIDA) awarded a $254,250 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to President and Fellows of Harvard College, doing business as Harvard Medical School, for the project "Control of Drug-Reward Behavior and Relapse Vulnerability via a Specialized Serotonergic-Septohippocampal Circuit." The project aims to explore a specialized brain circuit involving serotonin-producing neurons and their connections to...
This $1,447,919 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research into the development of cocaine addiction and interventions targeting the "need-state" hypothesis. The project aims to use an animal model to identify early markers of addiction vulnerability, measure associated neural activation patterns, and evaluate whether treatment with a GLP-1 receptor agonist can reverse these...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $903,965.00 to the University of Alabama at Birmingham (UAB) for a research project titled "Prefrontal Circuits Controlling Heroin Seeking." The goal of the project is to investigate the role of distinct prefrontal cortex subcircuits in regulating opioid-seeking behavior and relapse, as well as the potential involvement of the orexin...
The National Institute on Drug Abuse (NIDA) awarded a $267,310 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Miami. The grant aims to assess the functional role of calcitonin gene-related peptide (CGRP) expressing neurons in the parabrachial nucleus (CGRPPBN) in opioid reinforcement and withdrawal, as well as determine the associated gene expression and epigenetic changes. The research will explore the feasibility of targeting these neurons...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on conducting preclinical trials to investigate the use of Neuropeptide S (NPS) receptor-targeted molecules as a potential treatment for opioid use disorders. The $419,876 award, spanning the period from September 2024 to August 2026, will support proof-of-concept studies to determine if NPS receptor-targeted molecules can reduce oxycodone taking...
The National Institute on Drug Abuse (NIDA) awarded a $126,432 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan. The award, granted on June 26, 2025, will support the development of a platform to improve peptide caging of chemogenetic and optogenetic tools, specifically Chemical Activated Protein (CAP), to control opioid peptides. The goal is to use these tools in animal models to advance the understanding of...
This $314,225 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders. The study aims to: 1) Define the behavioral patterns of dual opioid-methamphetamine use disorders in a rodent model, and 2) Map neural activation patterns in the cortico-basal ganglia-thalamic circuit in response to opioid...
The National Institute on Drug Abuse (NIDA) awarded a $2,902,673 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Rutgers, The State University of New Jersey, with a sub-award to The Washington University. The grant aims to establish OPRM1 exon 7-associated variants as novel therapeutic targets for mitigating adverse effects of clinically used mu opioids, such as fentanyl and oxycodone, without altering their analgesic properties for pain management. The research...